FDA and device companies butt heads on overseas trial proposal-massdevice: Medtech industry lobbying group AdvaMed commended the FDA and generally lauded the agency's efforts to promote principals of "Good Clinical Practice" in international clinical trials, but warned that certain of the FDA's proposals may butt heads with rules governing medical information in other countries.
